Imagen de Portada

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Alison Hiong, James Lynam, Andrew Weickhardt, Shirley Wong, Shomik Sengupta, Paul Manohar, Lih‐Ming Wong, Philip Dundee, Nathan Lawrentschuk, Alison Y. Zhang, Angelyn Anton, Ajay Raghunath, Peter Gibbs, Ben Tran
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	BJUI Compass
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
por: Rachel Weng, et al.
Publicado: (2025)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
por: Serdar Turan, et al.
Publicado: (2025)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
por: Katherina Y. Chen, et al.
Publicado: (2026)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
por: Liam Mannion, et al.
Publicado: (2024)

Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
por: Shugo Yajima, et al.
Publicado: (2025)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
por: Kira Furlano, et al.
Publicado: (2024)

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
por: Sean Lim, et al.
Publicado: (2026)

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
por: Jacob Hanna, et al.
Publicado: (2026)

Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
por: Chase Peng Yun Ng, et al.
Publicado: (2025)

Retzius‐sparing radical prostatectomy: First 200 Australian cases
por: Troy Richard John Gianduzzo, et al.
Publicado: (2025)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
por: John Lahoud, et al.
Publicado: (2024)

Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
por: Makito Miyake, et al.
Publicado: (2025)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
por: Amandeep Arora, et al.
Publicado: (2025)

Comparing GreenLight PVP and HoLEP beyond 5 years: A systematic review of long‐term functional outcomes and reoperation rates
por: Arthur Yim, et al.
Publicado: (2025)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
por: Cameron E. Alexander, et al.
Publicado: (2024)

Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
por: Sean Lim, et al.
Publicado: (2024)

Comparative analysis of early outcomes of the first 150 cases of posterior approach robotic‐assisted radical prostatectomy and identification of the learning curve: A single‐surgeon series
por: Li June Tay, et al.
Publicado: (2025)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
por: Jennifer Ward, et al.
Publicado: (2025)

Bleeding us dry: The financial impact of full blood examinations in the immediate postoperative period
por: Bodie Chislett, et al.
Publicado: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)

Patient experience of bladder cancer: A data linkage study
por: Snehadhar Shah, et al.
Publicado: (2024)

Health utility value of overactive bladder in Japanese older adults
por: Takashi Yoshioka, et al.
Publicado: (2024)

Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
por: Joshua D. Cabral, et al.
Publicado: (2026)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
por: Liwu Guo, et al.
Publicado: (2024)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
por: Yin Zhou, et al.
Publicado: (2024)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)

Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
por: Sezgin Yeni, et al.
Publicado: (2025)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
por: Yu Ishizuya, et al.
Publicado: (2026)

Perioperative factors influencing immediate and long‐term continence after robot‐assisted radical prostatectomy
por: Till Rostalski, et al.
Publicado: (2026)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
por: Rodolfo Hurle, et al.
Publicado: (2025)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
por: Kunal K. Sindhu, et al.
Publicado: (2024)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)

Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
por: Rebecca Martin, et al.
Publicado: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
por: Mohammadmehdi Adhami, et al.
Publicado: (2026)

Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
por: William Chui, et al.
Publicado: (2024)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
por: Thomas Philip Cahill, et al.
Publicado: (2024)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)